Skip to main content
Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
21.49
-1.13 (-5.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Lyell Immunopharma Revenue

In the year 2025, Lyell Immunopharma had annual revenue of $36.00K, down -40.98%. Lyell Immunopharma had revenue of $6.00K in the quarter ending December 31, 2025, a decrease of -45.45%.

Revenue (ttm)
$36.00K
Revenue Growth
-40.98%
P/S Ratio
13,925.75
Revenue / Employee
$120
Employees
300
Market Cap
501.33M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202536.00K-25.00K-40.98%
Dec 31, 202461.00K-69.00K-53.08%
Dec 31, 2023130.00K-84.55M-99.85%
Dec 31, 202284.68M74.03M695.15%
Dec 31, 202110.65M2.89M37.31%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MiMedx Group 418.63M
Valneva SE 205.07M
4D Molecular Therapeutics 85.21M
ADC Therapeutics 81.36M
Fulcrum Therapeutics 80.00M
XOMA Royalty 52.15M
Upstream Bio 2.85M
Revenue Rankings

LYEL News

More News